The role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging

Medical Hypotheses

Volumn 77, Issue 2, 2011, Pages 174-178

  Luo, Cheng ^a   Urgard, Egon ^a   Vooder, Tõnu ^a   Metspalu, Andres ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; TRANSCRIPTION FACTOR NRF2;

AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL DEATH; EPITHELIUM; HUMAN; HYPOTHESIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AGING; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 79960623753     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.04.002     Document Type: Article

References (54)

1. McKanna J.A., Zhang M.Z., Wang J.L., Cheng H., Harris R.C. Constitutive expression of cyclooxygenase-2 in rat vas deferens. Am J Physiol 1998, 275:R227-R233.
2. Hinz B., Brune K. Cyclooxygenase-2, 10 years later. J Pharmacol Exp Ther 2002, 300(2):367-375.
3. Peng Luo.C., Santti Y., He ML R., Lin M.C. COX-1 and 2 expressions in sex-related organs of neonatally estrogen treated rats and in activated and non-activated macrophage RAW264.7 cells with phytoestrogen. Endocr. 2006, 29(1):161-167.
4. Grosser T., Fries S., FitzGerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006, 116(1):4-15.
5. Warner T.D., Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004, 18:790-804.
6. Luo C., He M.L., Bohlin L. Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial. Acta Pharmacol Sin 2005, 26(8):926-933.
7. Mukherjee D., Nissen S.E., Topol E.J. Risk of cardiovascular events associated with selective COX-2 Inhibitors. JAMA 2001, 286:954-959.
8. Bresalier R.S., Sandler R.S., Quan H., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092-1102.
9. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13(1):76-86.
10. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999, 5:69.
11. Kansanen E., Kivelä A.M., Levonen A.L. Regulation of Nrf2-dependent gene expression by 15-deoxy-Δ12, 14-prostaglandin J2. Free Radic Biol Med 2009, 47:1310-1317.
12. Karsten G. Lipid autacoids in inflammation and injury responses: A matter of privilege. Mol Interv 2008, 8(1):28-35.
13. Vecchio A.J., Simmons D.M., Malkowski M.G. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem 2010, 285(29):22152-22163.
14. Chen C. Lipids: COX-2's new role in inflammation. Nat Chem Biol 2010, 6:401-402.
15. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
16. Groeger A.L., Cipollina C., Cole M.P., Woodcock S.R., Bonacci G., Rudolph T.K., et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 2010, 6(6):433-441.
17. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24(16):7130-7139.
18. Sekhar K.R., Rachakonda G., Freeman M.L. Cysteine-based regulation of the CUL3 adaptor protein Keap1. Toxicol Appl Pharmacol 2009, 244(1):21-26.
19. Johnson J.A., Johnson D.A., Kraft A.D., Calkins M.J., Jakel R.J., Vargas M.R., et al. The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci 2008, 1147:61-69.
20. Ogura T., Tong K.I., Mio K., Maruyama Y., Kurokawa H., Sato C., et al. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc Natl Acad Sci USA 2010, 107(7):2842-2847.
21. Flower R.J. Prostaglandins, bioassay and inflammation. Br J Pharmacol 2006, 147:S182-S192.
22. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001, 2:612-619.
23. Rajakariar R., Yaqoob M.M., Gilroy D.W. COX-2 in inflammation and resolution. Mol Interv 2006, 6:199-207.
24. Rajakariar R., Hilliard M., Lawrence T., Trivedi S., Colville-Nash P., Bellingan G., et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxy 12-14 PGJ2. Proc Natl Acad Sci USA 2007, 104:20979-20984.
25. Haworth O., Buckley C.D. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci USA 2007, 104:20647-20648.
26. Kundu J.K., Surh Y.J. Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharm Res 2010, 27(6):999-1013.
27. Heymes C., Habib A., Yang D., Mathieu E., Marotte F., Samuel J.L., et al. Cyclooxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol 2000, 131(4):804-810.
28. Briones A.M., Salaices M., Vila E. Ageing alters the production of nitric oxide and prostanoids after IL-1beta exposure in mesenteric resistance arteries. Mech Ageing Dev 2005, 126(6-7):710-721.
29. Hur W., Gray N.S. Small molecule modulators of antioxidant response pathway. Curr Opin Chem Biol 2010, 15:1-12.
30. Surh Y.J., Na H.K. NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr 2008, 2:313-317.
31. Davidge S.T., Hubel C.A., McLaughlin M.K. Impairment of vascular function is associated with an age-related increase of lipid peroxidation in rats. Am J Physiol 1996, 271:R1625.
32. Stewart K.G., Zhang Y., Davidge S.T. Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries. Hypertension 2000, 35:1242.
33. Shi Y., Man R.Y., Vanhoutte P.M. Two isoforms of cyclooxygenase contribute to augmented endothelium-dependent contractions in femoral arteries of 1-year-old rats. Acta Pharmacol Sin 2008, 29(2):185-192.
34. Mattammal M.M.B., Strong R., Lakshmi V.M., Chung H.D., Stephenson A.H. Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease. J Neurochem 1995, 64:1645-1654.
35. Teismann T.P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., et al. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA 2003, 100:5473-5478.
36. Vardeh D., Wang D., Costigan M., Lazarus M., Saper C.B., Woolf C.J., et al. COX-2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest 2009, 119(2):287-294.
37. Vijitruth R., Liu M., Choi D.Y., Nguyen X.V., Hunter R.L., Bing G. Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. J Neuroinflamm 2006, 3:6.
38. Yang W., Tiffany-Castiglioni E., Lee M.Y., Son I.H. Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells. Toxicol Lett 2010, 199(3):239-246.
39. Rojo A.I., Innamorato N.G., Martín-Moreno A.M., De Ceballos M.L., Yamamoto M., Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 2010, 58(5):588-598.
40. Casolini P., Catalani A., Zuena A.R., Angelucci L. Inhibition of COX-2 reduces the agedependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res 2002, 68(3):337-343.
41. Mayahara K., Kobayashi Y., Takimoto K., Suzuki N., Mitsui N., Shimizu N. Aging stimulates cyclooxygenase-2 expression and prostaglandin E2 production in human periodontal ligament cells after the application of compressive force. J Periodontal Res 2007, 42(1):8-14.
42. Naruse K., Sekiya H., Harada Y., Iwabuchi S., Kozai Y., Kawamata R., et al. Prolonged endochondral bone healing in senescence is shortened by low-intensity pulsed ultrasound in a manner dependent on COX-2. Ultrasound Med Biol 2010, 6(7):1098-1108.
43. Seulgi Hur, Yun Sang Lee, Hyun Yoo, Jeong-Hee Yang, Tae-Yoon Kim Homoisoflavanone inhibits UVB-induced skin inflammation through reduced cyclooxygenase-2 expression and NFκB nuclear localization. J Dermatol Sci 2010, 59:163-169.
44. Melk A., Schmidt B.M., Takeuchi O., Sawitzki B., Rayner D.C., Halloran P.F. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 2004, 65(2):510-520.
45. Sáez F., Reverte V., Salazar F., Castells M.T., Llinás M.T., Salazar F.J. Hypertension and sex differences in the age-related renal changes when cyclooxygenase-2 activity is reduced during nephrogenesis. Hypertension 2009, 53:331-337.
46. Luo C., Kallajoki M., Gross R., Mulari M., Makinen M., Teros T., et al. Cellular distribution and contribution of cyclooxygenase (COX)-2 to diabetogenesis in NOD mouse. Cell Tissue Res 2002, 310(2):169-175.
47. Dey A., Maric C., Kaesemeyer W.H., Zaharis C.Z., Stewart J., Pollock J.S., et al. Rofecoxib decreases renal injury in obese Zucker rats. Clin Sci (Lond) 2004, 107(6):561-570.
48. Jung K.J., Lee E.K., Kim J.Y., Zou Y., Sung B., Heo H.S., et al. Effect of short term calorie restriction on pro-inflammatory NF-κB and AP-1 in aged rat kidney. Inflamm Res 2009, 58(3):143-150.
49. Stanfield K.M., Khan K.N. Localization of COX-2 in the male reproductive tract during sexual maturation. Inflammopharmacol 2003, 11(3):259-266.
50. Luo C., Strauss L., Streng T., Ristimaki A., Santti R. Constant expression of cyclooxygenase-2 gene in prostate and the lower urinary tract of estrogen-treated male rats. Zeitschrift Fur Naturforschung -C J. Biosciences 2001, 56(5-6):455-463.
51. Zdanov S., Toussaint O., Debacq-Chainiaux F. P53 and ATF-2 partly mediate the overexpression of COX-2 in H2O2-induced premature senescence of human fibroblasts. Biogerontology 2009, 10(3):291-298.
52. Siironen P., Ristimäki A., Nordling S., Louhimo J., Haapiainen R., Haglund C. Expression of COX-2 is increased with age in papillary thyroid cancer. Histopathology 2004, 44(5):490-497.
53. Mochizuki M., Ishii Y., Itoh K., Iizuka T., Morishima Y., Kimura T., et al. Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am J Respir Crit Care Med 2005, 171(11):1260-1266.
54. Välk K., Vooder T., Kolde R., Reintam M.A., Petzold C., Vilo J., et al. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology 2010, 79(3-4):283-292.